Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
AOUT American Outdoor Brands Inc posts 384 percent EPS surprise for Q1 2026 yet shares fall 2 percent today RIOT Riot Platforms Inc reports massive Q4 2025 EPS miss shares fall 386 percent as losses far outpace expectations CIT CINT Sector Leadership CI and T Inc posts 393 EPS beat topping analyst estimates SWZ Total executives outline longterm strategic priorities to boost operational efficiency and shareholder returns Matrix MTRX Stock Price Movement Outlook Volatility Increases 20260420 CCJ Cameco posts 125 Q4 2025 EPS beat yet shares fall 137 on mild investor profit taking How Cohen RFI pricing power shows up in earnings RFI Q3 Earnings Cohen Faces Challenging Real Estate Market Headwinds China Investor Acquires CenturyOld German Sewing Machine Manufacturer Duolingo DUOL Rallies 266 as Bulls Target 11766 20260515 Tax Season Updates New Rules for Online Sellers and EV Buyers Escalade Incorporated ESCA Slips 083 Testing 1754 Support 20260519 Is Bruker BRKR Still a Buy After 135 Rally 20260514 Karnataka Bank Reports Strong Q4 Profit Growth of 6174 Asset Quality Improves Oura Health How a Finnish Smart Ring Startup Became a Global Wearable Sensation Nifty 50s LongTerm Historical Performance Signals Resilience Amid ShortTerm Challenges FBI Seizes Record 8 Billion in Cryptocurrency in Global Crackdown on Scam Compounds Signos Raises 20 Million Expands Dexcom Partnership Amid GLP1 Weight Loss Trend SNC Scandic Coin Debuts as Regulated RealWorld Asset Project on Major Exchanges Park Medi World Could See Further Gains After 90 YTD Surge Brokerage Suggests ADAML Q1 2026 Earnings Preferred EPS Crushes Estimates by 75 as FixedtoFloating Rate Structure Gains Traction OPRT Q1 2026 Earnings EPS Surpasses Estimates by 243 Despite Stock Decline CGTX Q1 2026 Earnings Cognition Therapeutics Reports NarrowerThanExpected Loss No Revenue Yet PDS Biotechnology Q1 2026 Earnings Narrowed Loss Per Share and Clinical Progress Drive Positive Market Response MetLife MET Q1 2026 Earnings Earnings Beat Driven by Strong Underwriting and Investment Performance LB Pharmaceuticals LBRX Holds Near Resistance as Modest Gain Signals Consolidation Anixa Biosciences ANIX Slides 215 as Biotech Sector Headwinds Return Verra Mobility VRRM Climbs 09 as Stock Tests Resistance Near 1416 Mingteng International Corporation MTEN Rallies 79 as Stock Tests Key Resistance at 114 Nokia NOK Surges Over 9 Key Levels and Volume Analysis Sweetgreen SG Slips as Stock Fails to Hold 10 Level Eyes Support at 946 Intuitive Machines Shares Decline Amid Broader Market Concerns Robinhood Unveils AI Agent Trading and Credit Card Tools for Retail Investors